Hello and welcome to the details of Norway postpones decision on AstraZeneca jab, TV2 reports and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
OSLO, March 26 — Norway will delay its decision on whether to resume the use of AstraZeneca’s Covid-19 vaccine, broadcaster TV2 reported today, citing anonymous sources.
Authorities suspended the rollout of the vaccine two weeks ago after several younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died.
The TV2 report did not say how a delay would last.
Norway is one of over a dozen European countries to have suspended the rollout over safety concerns, although most nations have since resumed its use on the advice of the European Medicines Agency (EMA).
The Norwegian Institute of Public Health is due to publish its decision at 1200 CET (1100 GMT).
EMA has said the shot’s benefits in protecting people from coronavirus-related death or hospitalisation outweighed the possible risks. The World Health Organisation has also backed the jab.
AstraZeneca has said a review of safety data of more than 17 million people inoculated in the United Kingdom and European Union with its vaccine had shown no evidence of an increased risk of blood clots. — Reuters
These were the details of the news Norway postpones decision on AstraZeneca jab, TV2 reports for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.